Medical Condition News

RSS

Biogen Idec announces new data from BG-12 Phase 3 studies on RRMS

Today Biogen Idec announced new data from studies evaluating oral BG-12 (dimethyl fumarate), which provide further evidence supporting its strong clinical and radiological effects in people with relapsing-remitting multiple sclerosis (RRMS) and reinforce its favorable safety profile seen to date.

12 Oct 2012

Premature babies from low-income families more likely to develop brain hemorrhages

Babies born prematurely to low-income parents have a disproportionately high risk for developing dangerous brain bleeds that require multiple surgeries and extensive follow-up, according to a small Johns Hopkins Children's Center study.

12 Oct 2012

Early exposure to traffic-related air pollution affects respiratory health in children

Exposure to ambient air pollution from traffic during infancy is associated with lung function deficits in children up to eight years of age, particularly among children sensitized to common allergens, according to a new study.

12 Oct 2012

Single genetic variant in kidney donors' cells may play an important role in transplant longevity

A single genetic variant in kidney donors' cells may help determine whether their transplanted organs will survive long term, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

12 Oct 2012

Cardioviva can help fill the gap between diet, exercise and drugs

Over half (52 percent) of supplement users are concerned about their heart health and 73 percent express an interest in natural, clinically proven solutions for cholesterol reduction, according to market research conducted by Micropharma Limited, a pioneer in the development of innovative and effective probiotics.

12 Oct 2012

Insight into how coeliac disease is triggered

For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.

12 Oct 2012

Fruits and vegetables appear to improve mental wellbeing

Happiness and mental health are highest among people who eat seven portions of fruit and vegetables a day, according to a new report.

12 Oct 2012

Homeless Intermediate Care Pilot Project helps reduce hospital, ED admissions

A nurse outreach programme to treat people using a homeless shelter in London led to a fall of 77 per cent in hospital admissions from the shelter and a cut of 52 per cent in emergency department attendances.

12 Oct 2012

Simple quiz could help doctors determine kidney dialysis patients at risk of death

A simple six-question quiz, typically used to assess disabilities in the elderly, could help doctors determine which kidney dialysis patients of any age are at the greatest risk of death, new Johns Hopkins research suggests.

12 Oct 2012

LLS symposium to review latest advances in blood cancer research

A cadre of leading researchers in hematology, oncology, cell biology, and biotechnology are conducting presentations and discussions at this symposium to review the latest advances in blood cancer research.

12 Oct 2012

Results from Aldagen’s ALD-401 Phase II trial on ischemic stroke

Early results of a Phase II intra-arterial stem cell trial for ischemic stroke showed no adverse events associated with the first 10 patients, allowing investigators to expand the study to a targeted total of 100 patients.

12 Oct 2012

Two Boston University community members among new MAS Fellows

Two members of the Boston University community are among the new class of Fellows of the Massachusetts Academy of Sciences (MAS).

12 Oct 2012

Clinical study to investigate Cytori's adipose-derived cell therapy in patients with heart failure

Timothy Henry, M.D. of the Minneapolis Heart Institute Foundation treated the first patient in the ATHENA study, injecting the patient's own stem cells into the heart to restore blood flow and help regenerate heart muscle. Henry, the Foundation's Director of Research is co-principal investigator of the ATHENA study sponsored by Cytori Therapeutics.

12 Oct 2012

Regenstrief, IU to work with 19 Indiana nursing facilities to improve quality of care

A multi-million-dollar award from the Centers for Medicare & Medicaid Services, or CMS, will enable Indiana University and Regenstrief Institute clinician-researchers to work with 19 central Indiana nursing facilities to improve the quality of care, reduce hospitalizations and increase access to palliative care for long-stay nursing facility residents.

12 Oct 2012

Nelfinavir slows progress of HER2-positive tumor cells

After screening more than 2,300 drugs for their ability to halt the growth of breast cancer cells, Johns Hopkins researchers have discovered that the anti-HIV drug nelfinavir slows the progress of HER2-positive tumor cells, even if they are resistant to other breast cancer drugs.

12 Oct 2012

Protocol allows researchers to generate functional thyroid tissue from stem cells

The generation of functional thyroid tissue from stem cells could allow the treatment of patients, which suffer from thyroid hormone deficiency due to defective function, or abnormal development of the thyroid gland.

12 Oct 2012

T cells become more responsive in cancer survivors after exercise

Researchers may soon be able to add yet another item to the list of exercise's well-documented health benefits: A preliminary study suggests that when cancer survivors exercise for several weeks after they finish chemotherapy, their immune systems remodel themselves to become more effective, potentially fending off future incidences of cancer.

12 Oct 2012

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

The American Association for Cancer Research will host the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research at the Hilton Anaheim from Oct. 16-19, 2012.

12 Oct 2012

NRG1 gene plays an important role in cannabis dependence

A paper by Shizhong Han and colleagues in the current issue of Biological Psychiatry implicates a new gene in the risk for cannabis dependence. This gene, NRG1, codes for the ErbB4 receptor, a protein implicated in synaptic development and function.

12 Oct 2012

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Pfizer Inc. announced top-line results today from a Phase 3 open-label long-term safety study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic, non-cancer pain.

12 Oct 2012

Medical Condition News

Biogen Idec announces new data from BG-12 Phase 3 studies on RRMS

Premature babies from low-income families more likely to develop brain hemorrhages

Early exposure to traffic-related air pollution affects respiratory health in children

Single genetic variant in kidney donors' cells may play an important role in transplant longevity

Cardioviva can help fill the gap between diet, exercise and drugs

Insight into how coeliac disease is triggered

Fruits and vegetables appear to improve mental wellbeing

Homeless Intermediate Care Pilot Project helps reduce hospital, ED admissions

Simple quiz could help doctors determine kidney dialysis patients at risk of death

LLS symposium to review latest advances in blood cancer research

Results from Aldagen’s ALD-401 Phase II trial on ischemic stroke

Two Boston University community members among new MAS Fellows

Clinical study to investigate Cytori's adipose-derived cell therapy in patients with heart failure

Regenstrief, IU to work with 19 Indiana nursing facilities to improve quality of care

Nelfinavir slows progress of HER2-positive tumor cells

Protocol allows researchers to generate functional thyroid tissue from stem cells

T cells become more responsive in cancer survivors after exercise

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

NRG1 gene plays an important role in cannabis dependence

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News